Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram

Marc A. Bjurlin, Audrey Renson, Soroush Rais-Bahrami, Matthew Truong, Andrew B. Rosenkrantz, Richard Huang, Samir S. Taneja

Research output: Contribution to journalArticlepeer-review

Abstract

We externally validated a clinically useful tool that predicts benign prostate pathology on magnetic resonance imaging/ultrasound fusion–targeted biopsy in men with a prior negative 12-core systematic biopsy and updated this predictive tool to improve its performance in patient counseling regarding the need for a repeat biopsy.

Original languageEnglish (US)
Pages (from-to)815-822
Number of pages8
JournalEuropean Urology Focus
Volume5
Issue number5
DOIs
StatePublished - Sep 2019

Keywords

  • Benign
  • External validation
  • Magnetic resonance imaging/ultrasound fusion–targeted prostate biopsy
  • Nomogram
  • Prior negative biopsy
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Predicting Benign Prostate Pathology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Men with a Prior Negative 12-core Systematic Biopsy: External Validation of a Prognostic Nomogram'. Together they form a unique fingerprint.

Cite this